カテゴリー： QYResearch, 世界

世界の転移性骨腫瘍治療市場 2019年

【英語タイトル】Global Metastatic Bone Tumor Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11319）・商品コード：DATA909X11319
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、転移性骨腫瘍治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療に、用途別には、病院、がんリハビリテーションセンター、専門クリニック、外来手術センターにセグメント区分し、転移性骨腫瘍治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・転移性骨腫瘍治療の世界市場概要
・転移性骨腫瘍治療の製造コスト構成分析
・転移性骨腫瘍治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・転移性骨腫瘍治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・転移性骨腫瘍治療のセグメント分析（種類別）
（外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療）
・転移性骨腫瘍治療のセグメント分析（用途別）
（病院、がんリハビリテーションセンター、専門クリニック、外来手術センター）
・転移性骨腫瘍治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novartis AG、Amgen Inc、Catena Pharmaceuticals、Hoffmann-La Roche Ltd、Eli Lilly、Pfizer、）
・転移性骨腫瘍治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Metastatic Bone Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Metastatic Bone Tumor Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metastatic Bone Tumor Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Metastatic Bone Tumor Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Metastatic Bone Tumor Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis AG
Amgen Inc
Catena Pharmaceuticals
Hoffmann-La Roche Ltd
Eli Lilly
Pfizer
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
External Radiation Therapy
Chemotherapy
Hormone Therapy
Immunotherapy
Medications
Surgical treatment

Segment by Application
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Metastatic Bone Tumor Treatment
1.1 Definition of Metastatic Bone Tumor Treatment
1.2 Metastatic Bone Tumor Treatment Segment by Type
1.2.1 Global Metastatic Bone Tumor Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 External Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Hormone Therapy
1.2.5 Immunotherapy
1.2.6 Medications
1.2.7 Surgical treatment
1.3 Metastatic Bone Tumor Treatment Segment by Applications
1.3.1 Global Metastatic Bone Tumor Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Cancer Rehabilitation Centers
1.3.4 Specialty Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Global Metastatic Bone Tumor Treatment Overall Market
1.4.1 Global Metastatic Bone Tumor Treatment Revenue (2014-2025)
1.4.2 Global Metastatic Bone Tumor Treatment Production (2014-2025)
1.4.3 North America Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.4 Europe Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.5 China Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.6 Japan Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)
1.4.8 India Metastatic Bone Tumor Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Metastatic Bone Tumor Treatment
2.3 Manufacturing Process Analysis of Metastatic Bone Tumor Treatment
2.4 Industry Chain Structure of Metastatic Bone Tumor Treatment

3 Development and Manufacturing Plants Analysis of Metastatic Bone Tumor Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Metastatic Bone Tumor Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Metastatic Bone Tumor Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Metastatic Bone Tumor Treatment Production and Capacity Analysis
4.2 Metastatic Bone Tumor Treatment Revenue Analysis
4.3 Metastatic Bone Tumor Treatment Price Analysis
4.4 Market Concentration Degree

5 Metastatic Bone Tumor Treatment Regional Market Analysis
5.1 Metastatic Bone Tumor Treatment Production by Regions
5.1.1 Global Metastatic Bone Tumor Treatment Production by Regions
5.1.2 Global Metastatic Bone Tumor Treatment Revenue by Regions
5.2 Metastatic Bone Tumor Treatment Consumption by Regions
5.3 North America Metastatic Bone Tumor Treatment Market Analysis
5.3.1 North America Metastatic Bone Tumor Treatment Production
5.3.2 North America Metastatic Bone Tumor Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Metastatic Bone Tumor Treatment Import and Export
5.4 Europe Metastatic Bone Tumor Treatment Market Analysis
5.4.1 Europe Metastatic Bone Tumor Treatment Production
5.4.2 Europe Metastatic Bone Tumor Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Metastatic Bone Tumor Treatment Import and Export
5.5 China Metastatic Bone Tumor Treatment Market Analysis
5.5.1 China Metastatic Bone Tumor Treatment Production
5.5.2 China Metastatic Bone Tumor Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Metastatic Bone Tumor Treatment Import and Export
5.6 Japan Metastatic Bone Tumor Treatment Market Analysis
5.6.1 Japan Metastatic Bone Tumor Treatment Production
5.6.2 Japan Metastatic Bone Tumor Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Metastatic Bone Tumor Treatment Import and Export
5.7 Southeast Asia Metastatic Bone Tumor Treatment Market Analysis
5.7.1 Southeast Asia Metastatic Bone Tumor Treatment Production
5.7.2 Southeast Asia Metastatic Bone Tumor Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Metastatic Bone Tumor Treatment Import and Export
5.8 India Metastatic Bone Tumor Treatment Market Analysis
5.8.1 India Metastatic Bone Tumor Treatment Production
5.8.2 India Metastatic Bone Tumor Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Metastatic Bone Tumor Treatment Import and Export

6 Metastatic Bone Tumor Treatment Segment Market Analysis (by Type)
6.1 Global Metastatic Bone Tumor Treatment Production by Type
6.2 Global Metastatic Bone Tumor Treatment Revenue by Type
6.3 Metastatic Bone Tumor Treatment Price by Type

7 Metastatic Bone Tumor Treatment Segment Market Analysis (by Application)
7.1 Global Metastatic Bone Tumor Treatment Consumption by Application
7.2 Global Metastatic Bone Tumor Treatment Consumption Market Share by Application (2014-2019)

8 Metastatic Bone Tumor Treatment Major Manufacturers Analysis
8.1 Novartis AG
8.1.1 Novartis AG Metastatic Bone Tumor Treatment Production Sites and Area Served
8.1.2 Novartis AG Product Introduction, Application and Specification
8.1.3 Novartis AG Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen Inc
8.2.1 Amgen Inc Metastatic Bone Tumor Treatment Production Sites and Area Served
8.2.2 Amgen Inc Product Introduction, Application and Specification
8.2.3 Amgen Inc Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Catena Pharmaceuticals
8.3.1 Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Sites and Area Served
8.3.2 Catena Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hoffmann-La Roche Ltd
8.4.1 Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Sites and Area Served
8.4.2 Hoffmann-La Roche Ltd Product Introduction, Application and Specification
8.4.3 Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eli Lilly
8.5.1 Eli Lilly Metastatic Bone Tumor Treatment Production Sites and Area Served
8.5.2 Eli Lilly Product Introduction, Application and Specification
8.5.3 Eli Lilly Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer
8.6.1 Pfizer Metastatic Bone Tumor Treatment Production Sites and Area Served
8.6.2 Pfizer Product Introduction, Application and Specification
8.6.3 Pfizer Metastatic Bone Tumor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Metastatic Bone Tumor Treatment Market
9.1 Global Metastatic Bone Tumor Treatment Market Trend Analysis
9.1.1 Global Metastatic Bone Tumor Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Metastatic Bone Tumor Treatment Regional Market Trend
9.2.1 North America Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.2 Europe Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.3 China Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.4 Japan Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.5 Southeast Asia Metastatic Bone Tumor Treatment Forecast 2019-2025
9.2.6 India Metastatic Bone Tumor Treatment Forecast 2019-2025
9.3 Metastatic Bone Tumor Treatment Market Trend (Product Type)
9.4 Metastatic Bone Tumor Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Metastatic Bone Tumor Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Metastatic Bone Tumor Treatment
Table Global Metastatic Bone Tumor Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Production Market Share by Types in 2018
Figure External Radiation Therapy Product Picture
Figure Chemotherapy Product Picture
Figure Hormone Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Medications Product Picture
Figure Surgical treatment Product Picture
Table Global Metastatic Bone Tumor Treatment Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Cancer Rehabilitation Centers
Figure Specialty Clinics
Figure Ambulatory Surgical Centers
Figure Global Metastatic Bone Tumor Treatment Revenue (Million USD) (2014-2025)
Figure Global Metastatic Bone Tumor Treatment Production (K Units) (2014-2025)
Figure North America Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Europe Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure China Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Japan Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Figure India Metastatic Bone Tumor Treatment Market Size (Million USD) (2014-2025)
Table Metastatic Bone Tumor Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Metastatic Bone Tumor Treatment in 2018
Figure Manufacturing Process Analysis of Metastatic Bone Tumor Treatment
Figure Industry Chain Structure of Metastatic Bone Tumor Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Metastatic Bone Tumor Treatment Manufacturing Plants Distribution
Table Metastatic Bone Tumor Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Metastatic Bone Tumor Treatment Capacity (K Units) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Production (K Units) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Metastatic Bone Tumor Treatment Production Share by Manufacturers in 2018
Table Metastatic Bone Tumor Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Metastatic Bone Tumor Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Metastatic Bone Tumor Treatment Revenue Share by Manufacturers in 2018
Table Metastatic Bone Tumor Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Metastatic Bone Tumor Treatment Production by Regions 2014-2019 (K Units)
Table Global Metastatic Bone Tumor Treatment Production Market Share by Regions 2014-2019
Figure Global Metastatic Bone Tumor Treatment Production Market Share by Regions in 2018
Table Global Metastatic Bone Tumor Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Metastatic Bone Tumor Treatment Revenue Market Share by Regions 2014-2019
Figure Global Metastatic Bone Tumor Treatment Revenue Market Share by Regions in 2018
Table Global Metastatic Bone Tumor Treatment Consumption by Regions 2014-2019 (K Units)
Table Global Metastatic Bone Tumor Treatment Consumption Market Share by Regions 2014-2019
Figure North America Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure North America Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Europe Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Europe Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure China Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure China Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Japan Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Japan Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure India Metastatic Bone Tumor Treatment Production Growth Rate 2014-2019 (K Units)
Figure India Metastatic Bone Tumor Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Metastatic Bone Tumor Treatment Production, Consumption Import and Export (K Units)
Figure Global Consumption Metastatic Bone Tumor Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Metastatic Bone Tumor Treatment Market Share by Application (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Novartis AG Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Novartis AG Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Novartis AG Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Novartis AG Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Amgen Inc Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Amgen Inc Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Amgen Inc Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Amgen Inc Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Amgen Inc Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Catena Pharmaceuticals Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Eli Lilly Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Eli Lilly Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Eli Lilly Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Eli Lilly Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Eli Lilly Metastatic Bone Tumor Treatment Main Business and Markets Served
Table Pfizer Metastatic Bone Tumor Treatment Production Sites and Area Served
Table Pfizer Metastatic Bone Tumor Treatment Product Introduction, Application and Specification
Table Pfizer Metastatic Bone Tumor Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Production Growth Rate (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Production Market Share (2014-2019)
Figure Pfizer Metastatic Bone Tumor Treatment Revenue Market Share (2014-2019)
Table Pfizer Metastatic Bone Tumor Treatment Main Business and Markets Served
Figure Global Metastatic Bone Tumor Treatment Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Metastatic Bone Tumor Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Metastatic Bone Tumor Treatment Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Metastatic Bone Tumor Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Metastatic Bone Tumor Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Metastatic Bone Tumor Treatment by Type (2019-2025)
Table Global Consumption (K Units) of Metastatic Bone Tumor Treatment by Application (2019-2025)
Table Metastatic Bone Tumor Treatment Distributors List
Table Metastatic Bone Tumor Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis AG、Amgen Inc、Catena Pharmaceuticals、Hoffmann-La Roche Ltd、Eli Lilly、Pfizer、

★調査レポート[世界の転移性骨腫瘍治療市場 2019年] (コード：DATA909X11319)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の転移性骨腫瘍治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 神経内分泌腫瘍治療の世界市場：規模・現状・予測2019-2025
    DATA909X18748 / QYResearch / 2019年11月25日 / ※当調査レポートでは、神経内分泌腫瘍治療の世界市場について調査・分析し、神経内分泌腫瘍治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経内分泌腫瘍治療市場動向 ・主要企業別マーケットシェア ・神経内分泌腫瘍治療の種類別市場規模2014-2019 （エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド） ・神経内分泌腫瘍治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・神経内分泌腫瘍治療の北米市場：主要企業・種類別/用途別市場規模 ・神経内分泌腫瘍治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.In 2018, the global Neuroendocrine Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Neuroendocrine Tumor Treatment status, future forecast, growth opportunity, key market and...
  • 線維形成性小円形細胞腫瘍の治療の世界市場：規模・現状・予測2019-2025
    DATA909X18378 / QYResearch / 2019年11月25日 / ※当調査レポートでは、線維形成性小円形細胞腫瘍の治療の世界市場について調査・分析し、線維形成性小円形細胞腫瘍の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫療法、外科手術、化学療法、放射線療法）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の線維形成性小円形細胞腫瘍の治療市場動向 ・主要企業別マーケットシェア ・線維形成性小円形細胞腫瘍の治療の種類別市場規模2014-2019 （免疫療法、外科手術、化学療法、放射線療法） ・線維形成性小円形細胞腫瘍の治療の用途別市場規模2014-2019 （病院、診療所、その他） ・線維形成性小円形細胞腫瘍の治療の北米市場：主要企業・種類別/用途別市場規模 ・線維形成性小円形細胞腫瘍の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Desmoplastic Small Round Cell Tumor Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Desmoplastic Small Round Cell Tumor Treatment development in...
  • 世界の骨髄移植拒絶反応の治療市場 2019年
    DATA909X04747 / QYResearch / 2019年11月15日 / ※本調査レポートは、骨髄移植拒絶反応の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザチオプリン、副腎皮質刺激ホルモン、シクロホスファミド、シクロスポリンA、その他に、用途別には、病院、診療所、その他にセグメント区分し、骨髄移植拒絶反応の治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・骨髄移植拒絶反応の治療の世界市場概要 ・骨髄移植拒絶反応の治療の製造コスト構成分析 ・骨髄移植拒絶反応の治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・骨髄移植拒絶反応の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・骨髄移植拒絶反応の治療のセグメント分析（種類別） （アザチオプリン、副腎皮質刺激ホルモン、シクロホスファミド、シクロスポリンA、その他）...The global Bone Marrow Transplant Rejection Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Bone Marrow Transplant Rejection Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bone Marrow Transplant Rejection Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Bone Marrow Transplant Rejection Treatment in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のウィルムス腫瘍タンパク質市場 2019年
    DATA909X17797 / QYResearch / 2019年11月22日 / ※本調査レポートは、ウィルムス腫瘍タンパク質の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他に、用途別には、副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他にセグメント区分し、ウィルムス腫瘍タンパク質の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ウィルムス腫瘍タンパク質の世界市場概要 ・ウィルムス腫瘍タンパク質の製造コスト構成分析 ・ウィルムス腫瘍タンパク質の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ウィルムス腫瘍タンパク質の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ウィルムス腫瘍タンパク質のセグメント分析（種類別） （Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他）...The global Wilms Tumor Protein market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wilms Tumor Protein volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wilms Tumor Protein market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wilms Tumor Protein in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆